A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy
- 1. Medical Physics Department, Cookridge Hospital, Leeds (United Kingdom)
Description
Purpose: Prediction of the number of iodine seeds (I-125) required for prostate implantation is an important tool to reduce the number of unused seeds for brachytherapy. This study was designed to investigate the relationship between the number of seeds implanted vs. prostate volume. This can produce a tool to accurately estimate the number of seeds required for a given target volume. In addition, total cost of treatment, personal radiation risks during storage and handling, and errors in accounting for seeds can be reduced. Methods and Materials: Data from two groups of patients who had I-125 seed prostate implants (Oncura/Amersham RAPIDStrand model 6711 I-125) have been separately analyzed: (A) The relationship between prostate volume vs. number of seeds implanted was based on 401 patients treated between 1999 and 2002 who were implanted with seeds of air kerma strength (AKS) of 0.459 μGyh-1 at 1 m per seed. (B) The relationship between prostate volume vs. total seed AKS was analyzed. This was based on 628 patients treated between 1999 and 2002 who were implanted with a range of seed strengths from 0.381 to 0.521 U. Both patient groups were subdivided into integer prostate volume bins. For each bin, the mean and 95% confidence intervals (CI) for the implanted number of seeds or total AKS implanted were calculated. The upper 95% CI was used to investigate the relationship between the number of seeds implanted and total AKS implanted vs. prostate volume. Results: The new method of predicting the number of seeds shows valid and accurate results. The required number of seeds can be predicted, which helps to reduce the number of leftover seeds to 3% of the total number of seeds ordered. Conclusion: The number of I-125 seeds or the total activity that is required to deliver the prescribed dose for the target volume can be predicted. This could reduce the overall treatment cost by accurate seed ordering before implantation
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2005.12.030;
- PII
- S0360-3016(06)00080-0;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 65
- Journal Issue
- 1
- Journal Page Range
- p. 304-307
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 37095126
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRACHYTHERAPY; ERRORS; IODINE 125; KERMA; PATIENTS; PROSTATE; RADIATION DOSES; RADIATION SOURCE IMPLANTS
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DOSES; ELECTRON CAPTURE RADIOISOTOPES; GLANDS; IMPLANTS; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IODINE ISOTOPES; ISOTOPES; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIATION SOURCES; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.